You have free access to this content

Hepatology

Cover image for Vol. 57 Issue 1

January 2013

Volume 57, Issue 1

Pages 1–428

  1. Editorials

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Hepatology Elsewhere
    11. Clinical Observations in Hepatology
    12. Correspondence
    13. Correction
    14. Referees
    1. You have free access to this content
    2. You have free access to this content
      Human immunodeficiency virus and hepatitis c virus coinfection: The agenda is full while waiting for new drugs (pages 4–6)

      Massimo Puoti, Maria Cristina Moioli, Roberto Rossotti, Giovanna Travi and Raffaele Bruno

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25941

    3. You have free access to this content
    4. You have free access to this content
  2. Viral Hepatitis

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Hepatology Elsewhere
    11. Clinical Observations in Hepatology
    12. Correspondence
    13. Correction
    14. Referees
    1. You have free access to this content
      Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B (pages 13–22)

      Simon P. Fletcher, Daniel J. Chin, Donavan T. Cheng, Palanikumar Ravindran, Hans Bitter, Lore Gruenbaum, Paul J. Cote, Han Ma, Klaus Klumpp and Stephan Menne

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25954

    2. You have free access to this content
      CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-jun N terminal kinase activation independent from the interferon pathway (pages 23–36)

      Sibylle J. Rau, Eberhard Hildt, Kiyoshi Himmelsbach, Robert Thimme, Takaji Wakita, Hubert E. Blum and Richard Fischer

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25966

    3. You have free access to this content
    4. You have free access to this content
      Hepatitis C virus NS4B protein targets STING and abrogates RIG-I–mediated type I interferon-dependent innate immunity (pages 46–58)

      Sayuri Nitta, Naoya Sakamoto, Mina Nakagawa, Sei Kakinuma, Kako Mishima, Akiko Kusano-Kitazume, Kei Kiyohashi, Miyako Murakawa, Yuki Nishimura-Sakurai, Seishin Azuma, Megumi Tasaka-Fujita, Yasuhiro Asahina, Mitsutoshi Yoneyama, Takashi Fujita and Mamoru Watanabe

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.26017

    5. You have free access to this content
      Differentiated umbilical cord matrix stem cells as a new in vitro model to study early events during hepatitis B virus infection (pages 59–69)

      Massimiliano Paganelli, Kai Dallmeier, Omar Nyabi, Isabelle Scheers, Benoît Kabamba, Johan Neyts, Patrick Goubau, Mustapha Najimi and Etienne M. Sokal

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.26006

    6. You have free access to this content
  3. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Hepatology Elsewhere
    11. Clinical Observations in Hepatology
    12. Correspondence
    13. Correction
    14. Referees
    1. You have free access to this content
      Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis (pages 81–92)

      Christopher Savard, Erica V. Tartaglione, Rahul Kuver, W. Geoffrey Haigh, Geoffrey C. Farrell, Savitha Subramanian, Alan Chait, Matthew M. Yeh, LeBris S. Quinn and George N. Ioannou

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25789

    2. You have free access to this content
      Glycogen synthase kinase 3-mediated voltage-dependent anion channel phosphorylation controls outer mitochondrial membrane permeability during lipid accumulation (pages 93–102)

      Cecile Martel, Maya Allouche, Davide Degli Esposti, Elena Fanelli, Céline Boursier, Céline Henry, Joel Chopineau, Giuseppe Calamita, Guido Kroemer, Antoinette Lemoine and Catherine Brenner

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25967

    3. You have free access to this content
      Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease (pages 103–111)

      Sudeep Tanwar, Paul M. Trembling, Indra N. Guha, Julie Parkes, Philip Kaye, Alastair D. Burt, Stephen D. Ryder, Guruprasad P. Aithal, Christopher P. Day and William M. Rosenberg

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.26030

  4. Hepatobiliary Malignancies

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Hepatology Elsewhere
    11. Clinical Observations in Hepatology
    12. Correspondence
    13. Correction
    14. Referees
    1. You have free access to this content
      Performance status in patients with hepatocellular carcinoma: Determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system (pages 112–119)

      Chia-Yang Hsu, Yun-Hsuan Lee, Cheng-Yuan Hsia, Yi-Hsiang Huang, Chien-Wei Su, Han-Chieh Lin, Rheun-Chuan Lee, Yi-You Chiou, Fa-Yauh Lee and Teh-Ia Huo

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25950

    2. You have free access to this content
      Sex bias occurrence of hepatocellular carcinoma in Poly7 molecular subclass is associated with EGFR (pages 120–130)

      Vincent W. Keng, Daniela Sia, Aaron L. Sarver, Barbara R. Tschida, Danhua Fan, Clara Alsinet, Manel Solé, Wai L. Lee, Timothy P. Kuka, Branden S. Moriarity, Augusto Villanueva, Adam J. Dupuy, Jesse D. Riordan, Jason B. Bell, Kevin A. T.Silverstein, Josep M. Llovet and David A. Largaespada

      Version of Record online: 19 OCT 2012 | DOI: 10.1002/hep.26004

    3. You have free access to this content
    4. You have free access to this content
      Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity (pages 140–151)

      Yuanyuan Guo, Wendie Wang, Jing Wang, Jiannan Feng, Qingyang Wang, Jianfeng Jin, Ming Lv, Xinying Li, Yan Li, Yuanfang Ma, Beifen Shen and Jiyan Zhang

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25978

    5. You have free access to this content
    6. You have free access to this content
      MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression (pages 162–170)

      Akemi Takata, Motoyuki Otsuka, Takeshi Yoshikawa, Takahiro Kishikawa, Yohko Hikiba, Shuntaro Obi, Tadashi Goto, Young Jun Kang, Shin Maeda, Haruhiko Yoshida, Masao Omata, Hiroshi Asahara and Kazuhiko Koike

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.26011

    7. You have free access to this content
      Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice (pages 171–182)

      Heng Lin, Jun Yan, Ziyan Wang, Fang Hua, Jiaojiao Yu, Wei Sun, Ke Li, Hong Liu, Hongzhen Yang, Qi Lv, Jianfei Xue and Zhuo-Wei Hu

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25991

    8. You have free access to this content
      Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer (pages 183–194)

      Alexander Pedroza-Gonzalez, Cornelis Verhoef, Jan N. M. Ijzermans, Maikel P. Peppelenbosch, Jaap Kwekkeboom, Joanne Verheij, Harry L. A. Janssen and Dave Sprengers

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.26013

    9. You have free access to this content
      A functional screening identifies five micrornas controlling glypican-3: role of mir-1271 down-regulation in hepatocellular carcinoma (pages 195–204)

      Marion Maurel, Sandra Jalvy, Yannick Ladeiro, Chantal Combe, Laetitia Vachet, Francis Sagliocco, Paulette Bioulac-Sage, Vincent Pitard, Hélène Jacquemin-Sablon, Jessica Zucman-Rossi, Benoît Laloo and Christophe F. Grosset

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25994

    10. You have free access to this content
      Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/Entpd1 null Mice (pages 205–216)

      Xiaofeng Sun, Lihui Han, Pankaj Seth, Shu Bian, Linglin Li, Eva Csizmadia, Wolfgang G. Junger, Moritz Schmelzle, Anny Usheva, Elliot B. Tapper, Gyorgy Baffy, Vikas P. Sukhatme, Yan Wu and Simon C. Robson

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25989

  5. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Hepatology Elsewhere
    11. Clinical Observations in Hepatology
    12. Correspondence
    13. Correction
    14. Referees
    1. You have free access to this content
    2. You have free access to this content
      Scavenger receptor a restrains T-cell activation and protects against concanavalin A-induced hepatic injury (pages 228–238)

      Daming Zuo, Xiaofei Yu, Chunqing Guo, Hongxia Wang, Jie Qian, Huanfa Yi, Xiao Lu, Zhi-Ping Lv, John R. Subjeck, Huiping Zhou, Arun J. Sanyal, Zhengliang Chen and Xiang-Yang Wang

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25983

  6. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Hepatology Elsewhere
    11. Clinical Observations in Hepatology
    12. Correspondence
    13. Correction
    14. Referees
    1. You have free access to this content
      Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients (pages 239–248)

      Josh Levitsky, James M. Mathew, Michael Abecassis, Anat Tambur, Joseph Leventhal, Dhivya Chandrasekaran, Nancy Herrera, Patrice Al-Saden, Lorenzo Gallon, Anmaar Abdul-Nabi, Guang-Yu Yang, Sunil M. Kurian, Daniel R. Salomon and Joshua Miller

      Version of Record online: 17 JUL 2012 | DOI: 10.1002/hep.25579

    2. You have free access to this content
      The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection (pages 249–257)

      George N. Ioannou, Christopher L. Bryson, Noel S. Weiss, Richard Miller, John D. Scott and Edward J. Boyko

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25800

    3. You have free access to this content
      Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptake (pages 258–265)

      Gitte Dam, Susanne Keiding, Ole L. Munk, Peter Ott, Hendrik Vilstrup, Lasse K. Bak, Helle S. Waagepetersen, Arne Schousboe and Michael Sørensen

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25995

    4. You have free access to this content
      Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms (pages 266–276)

      Alessia Bortoluzzi, Giulio Ceolotto, Elisabetta Gola, Antonietta Sticca, Sergio Bova, Filippo Morando, Salvatore Piano, Silvano Fasolato, Silvia Rosi, Angelo Gatta and Paolo Angeli

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.26021

  7. Liver Injury/Regeneration

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Hepatology Elsewhere
    11. Clinical Observations in Hepatology
    12. Correspondence
    13. Correction
    14. Referees
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration (pages 299–310)

      Qinggong Yuan, Komal Loya, Bhavna Rani, Selina Möbus, Asha Balakrishnan, Jutta Lamle, Toni Cathomen, Arndt Vogel, Michael P. Manns, Michael Ott, Tobias Cantz and Amar Deep Sharma

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25984

    4. You have free access to this content
      Human liver stem cells improve liver injury in a model of fulminant liver failure (pages 311–319)

      Maria Beatriz Herrera, Valentina Fonsato, Stefania Bruno, Cristina Grange, Nicholas Gilbo, Renato Romagnoli, Ciro Tetta and Giovanni Camussi

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25986

    5. You have free access to this content
      Directly acting drugs prostacyclin or nitroglycerine and endothelin receptor blocker bosentan improve cell engraftment in rodent liver (pages 320–330)

      Ralf Bahde, Sorabh Kapoor, Sriram Bandi, Kuldeep K. Bhargava, Christopher J. Palestro and Sanjeev Gupta

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.26005

    6. You have free access to this content
      Roles of hepatocyte and myeloid CXC chemokine receptor-2 in liver recovery and regeneration after ischemia/reperfusion in mice (pages 331–338)

      Heather L. Van Sweringen, Nozomu Sakai, Ralph C. Quillin, Jeff Bailey, Rebecca Schuster, John Blanchard, Holly Goetzman, Charles C. Caldwell, Michael J. Edwards and Alex B. Lentsch

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.26049

    7. You have free access to this content
      A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice (pages 339–350)

      Juan E. Puche, Youngmin A. Lee, Jingjing Jiao, Costica Aloman, Maria I. Fiel, Ursula Muñoz, Thomas Kraus, Tingfang Lee, Hal F. Yee Jr. and Scott L. Friedman

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.26053

    8. You have free access to this content
      Interferon regulatory factor 3 deficiency leads to interleukin-17-mediated liver ischemia-reperfusion injury (pages 351–361)

      Patrizia Loi, Qing Yuan, David Torres, Sandrine Delbauve, Marie-Aline Laute, Marie-Claude Lalmand, Michel Pétein, Stanislas Goriely, Michel Goldman and Véronique Flamand

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.26022

    9. You have free access to this content
      Interferon-gamma–mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice (pages 362–372)

      Junko Kato, Tomohiro Okamoto, Hiroyuki Motoyama, Ryosuke Uchiyama, Daniel Kirchhofer, Nico Van Rooijen, Hirayuki Enomoto, Shuhei Nishiguchi, Norifumi Kawada, Jiro Fujimoto and Hiroko Tsutsui

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.26027

  8. Liver Biology/Pathobiology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Hepatology Elsewhere
    11. Clinical Observations in Hepatology
    12. Correspondence
    13. Correction
    14. Referees
    1. You have free access to this content
    2. You have free access to this content
      Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics (pages 385–398)

      Evaggelia Liaskou, Henning W. Zimmermann, Ka-Kit Li, Ye H. Oo, Shankar Suresh, Zania Stamataki, Omar Qureshi, Patricia F. Lalor, Jean Shaw, Wing-kin Syn, Stuart M. Curbishley and David H. Adams

      Version of Record online: 4 DEC 2012 | DOI: 10.1002/hep.26016

    1. You have free access to this content
  9. Hepatology Elsewhere

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Hepatology Elsewhere
    11. Clinical Observations in Hepatology
    12. Correspondence
    13. Correction
    14. Referees
    1. You have free access to this content
    2. You have free access to this content
  10. Clinical Observations in Hepatology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Hepatology Elsewhere
    11. Clinical Observations in Hepatology
    12. Correspondence
    13. Correction
    14. Referees
    1. You have free access to this content
      A potential novel use for direct antiviral therapy (pages 414–415)

      Emre Turer, Don C. Rockey and Amit G. Singal

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.26145

  11. Correspondence

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Hepatology Elsewhere
    11. Clinical Observations in Hepatology
    12. Correspondence
    13. Correction
    14. Referees
    1. You have free access to this content
      Is there need for more than one IL28B single nucleotide polymorphism in hepatitis C clinical practice? (page 416)

      Enrico Galmozzi, Stella De Nicola, Alessio Aghemo and Massimo Colombo

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25927

    2. You have free access to this content
      Impact of cohort size and host factors on combined analysis of interleukin 28B rs12979860 and rs8099917 in hepatitis C virus infection (pages 416–417)

      Janett Fischer, Stephan Böhm, Jacob George, Christoph Sarrazin and Thomas Berg

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25923

    3. You have free access to this content
      Plasma lysophosphatidic acid levels and hepatocellular carcinoma (pages 417–418)

      Hitoshi Ikeda, Kenichiro Enooku, Ryunosuke Ohkawa, Kazuhiko Koike and Yutaka Yatomi

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25886

    4. You have free access to this content
      Reply (pages 418–419)

      Antonio Mazzocca and Gianluigi Giannelli

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25883

    5. You have free access to this content
      Pathophysiological relevance of neutrophils in acetaminophen hepatotoxicity (page 419)

      Hartmut Jaeschke, Mitchell R. McGill and C. David Williams

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25877

    6. You have free access to this content
      Reply (pages 420–421)

      Pedro Elias Marques, Sylvia Stella Amaral and Gustavo Batista Menezes

      Version of Record online: 13 NOV 2012 | DOI: 10.1002/hep.25884

    7. You have free access to this content
      The risk association between experimental portal hypertension and an aortic atherosclerosis-like disease (pages 421–422)

      Natalia De las Heras, Maria-Angeles Aller, Jaime Arias and Vicente Lahera

      Version of Record online: 20 SEP 2012 | DOI: 10.1002/hep.25917

    8. You have free access to this content
      Reply (page 422)

      Salvatore Petta and Antonio Craxì

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.25916

  12. Correction

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Hepatology Elsewhere
    11. Clinical Observations in Hepatology
    12. Correspondence
    13. Correction
    14. Referees
    1. You have free access to this content
      Correction (page 423)

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.26163

  13. Referees

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Hepatology Elsewhere
    11. Clinical Observations in Hepatology
    12. Correspondence
    13. Correction
    14. Referees
    1. You have free access to this content

SEARCH

SEARCH BY CITATION